These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 25636076

  • 1. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
    Fukami K, Yamagishi S, Sakai K, Kaida Y, Yokoro M, Ueda S, Wada Y, Takeuchi M, Shimizu M, Yamazaki H, Okuda S.
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
    [Abstract] [Full Text] [Related]

  • 2. L-Carnitine Supplementation Increases Trimethylamine-N-Oxide but not Markers of Atherosclerosis in Healthy Aged Women.
    Samulak JJ, Sawicka AK, Hartmane D, Grinberga S, Pugovics O, Lysiak-Szydlowska W, Olek RA.
    Ann Nutr Metab; 2019 Mar; 74(1):11-17. PubMed ID: 30485835
    [Abstract] [Full Text] [Related]

  • 3. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial.
    Tabibi H, Hakeshzadeh F, Hedayati M, Malakoutian T.
    J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850
    [Abstract] [Full Text] [Related]

  • 4. Dietary, anthropometric, and biochemical factors influencing plasma choline, carnitine, trimethylamine, and trimethylamine-N-oxide concentrations.
    Malinowska AM, Szwengiel A, Chmurzynska A.
    Int J Food Sci Nutr; 2017 Jun; 68(4):488-495. PubMed ID: 27855528
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V, Eleftheriadis T, Kyropoulos T, Voliotis G, Potamianos S, Zengos N, Stefanidis I, Heintz B.
    Ren Fail; 2005 Jun; 27(3):315-21. PubMed ID: 15957549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.
    Fukami K, Yamagishi S, Sakai K, Kaida Y, Adachi T, Ando R, Okuda S.
    Rejuvenation Res; 2013 Dec; 16(6):460-6. PubMed ID: 23909402
    [Abstract] [Full Text] [Related]

  • 10. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Skagen K, Trøseid M, Ueland T, Holm S, Abbas A, Gregersen I, Kummen M, Bjerkeli V, Reier-Nilsen F, Russell D, Svardal A, Karlsen TH, Aukrust P, Berge RK, Hov JE, Halvorsen B, Skjelland M.
    Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
    [Abstract] [Full Text] [Related]

  • 11. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.
    Collins HL, Drazul-Schrader D, Sulpizio AC, Koster PD, Williamson Y, Adelman SJ, Owen K, Sanli T, Bellamine A.
    Atherosclerosis; 2016 Jan; 244():29-37. PubMed ID: 26584136
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients.
    Cheng CH, Chen YS, Shu KH, Chang HR, Chou MC.
    Nephrology (Carlton); 2012 Nov; 17(8):718-24. PubMed ID: 22905988
    [Abstract] [Full Text] [Related]

  • 14. The Effect of Different l-Carnitine Administration Routes on the Development of Atherosclerosis in ApoE Knockout Mice.
    Zhao Y, Yang N, Gao J, Li H, Cai W, Zhang X, Ma Y, Niu X, Yang G, Zhou X, Li Y.
    Mol Nutr Food Res; 2018 Mar; 62(5):. PubMed ID: 29178259
    [Abstract] [Full Text] [Related]

  • 15. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
    Dambrova M, Latkovskis G, Kuka J, Strele I, Konrade I, Grinberga S, Hartmane D, Pugovics O, Erglis A, Liepinsh E.
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
    [Abstract] [Full Text] [Related]

  • 16. Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients.
    Kocijancic M, Cubranic Z, Vujicic B, Racki S, Dvornik S, Zaputovic L.
    Int Urol Nephrol; 2016 Jul; 48(7):1145-54. PubMed ID: 27023478
    [Abstract] [Full Text] [Related]

  • 17. Oolong Tea Extract and Citrus Peel Polymethoxyflavones Reduce Transformation of l-Carnitine to Trimethylamine-N-Oxide and Decrease Vascular Inflammation in l-Carnitine Feeding Mice.
    Chen PY, Li S, Koh YC, Wu JC, Yang MJ, Ho CT, Pan MH.
    J Agric Food Chem; 2019 Jul 17; 67(28):7869-7879. PubMed ID: 31287296
    [Abstract] [Full Text] [Related]

  • 18. The role of oral L-carnitine therapy in chronic hemodialysis patients.
    Sabry AA.
    Saudi J Kidney Dis Transpl; 2010 May 17; 21(3):454-9. PubMed ID: 20427868
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2008 May 17; 76(1):52-6. PubMed ID: 18474381
    [Abstract] [Full Text] [Related]

  • 20. A Pilot Study on the Effects of l-Carnitine and Trimethylamine-N-Oxide on Platelet Mitochondrial DNA Methylation and CVD Biomarkers in Aged Women.
    Bordoni L, Sawicka AK, Szarmach A, Winklewski PJ, Olek RA, Gabbianelli R.
    Int J Mol Sci; 2020 Feb 05; 21(3):. PubMed ID: 32033285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.